This Article Full Text Full Text (PDF) All Versions of this Article: 91/3/1015    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Masi, C. M. Articles by Cacioppo, J. T. Search for Related Content PubMed PubMed Citation Articles by Masi, C. M. Articles by Cacioppo, J. T. Related Collections Cardiovascular Endocrinology Female Endocrinology

Estrogen Metabolites and Systolic Blood Pressure in a Population-Based Sample of Postmenopausal Women

Department of Medicine (C.M.M.), Center for Cognitive and Social Neuroscience (C.M.M., L.C.H., J.D.B., J.T.C.), Department of Psychology (L.C.H., J.T.C.), University of Chicago, Chicago, Illinois 60637; and Department of Preventive Medicine (J.D.B.), Northwestern University Medical Center, Chicago, Illinois 60611

Address all correspondence and requests for reprints to: Dr. Christopher Masi, Department of Medicine, University of Chicago, 5841 South Maryland Avenue, Chicago, Illinois 60637. E-mail: cmasi{at}medicine.bsd.uchicago.edu.

Context: Lower systolic blood pressure (SBP) and lower rates of coronary heart disease among premenopausal women compared with similarly aged men and postmenopausal women suggest that female sex hormones may confer cardiovascular protection. 2-Hydroxyestradiol, a product of 17ß-estradiol oxidative metabolism, inhibits the proliferation of vascular smooth muscle cells in vitro. The other major product of 17ß-estradiol oxidative metabolism, 16-hydroxyestradiol, does not demonstrate similar inhibitory effects. Concentrations of 2-hydroxyestrone (2-OHE) and 16-hydroxyestrone (16-OHE) in urine reflect the relative activity of the 2- and 16-hydroxylation pathways of 17ß-estradiol.

Objective: The objective of this study was to determine the relationship between SBP and the ratio of 2-OHE to 16-OHE in urine.

Design and Participants: This was a cross-sectional study of 80 postmenopausal women living in Cook County, Illinois.

Setting: This study was performed in an academic clinical laboratory.

Main Outcome Measure: The main outcome measure was SBP.

Results: Women taking hormone replacement therapy had higher levels of urinary 2-OHE and 16-OHE, but their mean 2:16-OHE ratio and SBP did not differ from that of women not taking hormone replacement therapy. In a multivariate regression model that controlled for age, body mass index, race/ethnicity, and antihypertensive medication use, a SD increase in the 2:16-OHE ratio was associated with a 6.7-mm Hg decrease (P < 0.05) in SBP.

Conclusions: The ratio of urinary 2-OHE to 16-OHE is a significant predictor of SBP among postmenopausal women and may reflect the effects of 2-hydroxyestradiol, a potent inhibitor of vascular smooth muscle cell proliferation.